Questions about registration? Email email@example.com
Earn up to 14.75 CME Credits!
The syndrome of right heart failure is poorly understood and defined. Clinicians often fail to diagnose early stages of the disease and allow the manifestations to progress to severe disability. There is a pressing need to define, understand, and inculcate awareness about this disease in clinicians. Similarly, understanding right heart dysfunction requires focused investigations and research study, best brought forth by a multidisciplinary collaboration. This program is intended for clinical and research professionals who are involved in the care of patients with, and the study of, right heart disease, congenital heart disease, pulmonary hypertension, and associated disorders.
Covered topics include:
- Advanced right heart failure
- Valvular heart disease
- Chronic thromboembolic pulmonary hypertension
- Pulmonary heart disease
- Venous thrombosis
Under the Direction of Aaron Waxman, MD, PhD
This program is designed for:
- Nurse practitioners
- Physician assistants
- Allied health professionals
In the following fields:
- Critical care medicine
- Emergency medicine
- Internal medicine
- Vascular medicine
The 2021 5th Right Heart Summit will:
- Place emphasis on the current state and understanding of right heart adaptation and maladaptation.
- Facilitate in-depth discussions on evaluating best practices in diagnosing and managing patients with right heart failure.
- Provide opportunities to exchange ideas and dialogues between faculty and attendees.
At the end of this program, participants should be able to:
- Describe the unique structure and function of the right ventricle (RV) with focus on anatomical and embryological differences between the RV and LV
- Discuss the importance of RV and Pulmonary Arterial coupling and its role in RV function and RV failure
- Summarize the emerging role of advanced imaging in assessing RV function
- Evaluate the current data regarding myocardial metabolism and RV function
- Describe RV adaptation and maladaptation in pulmonary arterial hypertension
- Assess the effectiveness and adequacy of current therapies used in management of PAH
- Healthcare Providers: $200
- Industry Representatives: $300
- Your tuition includes
- 14.75 CME credits
- Welcome reception
- Continental breakfast
- Morning and afternoon coffee breaks
- Complimentary internet in the meeting room
- All attendees will receive a printed syllabus
Continuing Education Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of ScientiaCME and NATF. ScientiaCME is accredited by the ACCME to provide continuing medical education for physicians. ScientiaCME designates this educational activity for a maximum of 14.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nurse Practitioners (NPs)
The American Academy of Nurse Practitioners accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. ScientiaCME will provide NPs who successfully complete each activity with a certificate of participation indicating that the activity was designated for AMA PRA Category 1 Credit(s)™.
The American Academy of Physician Assistants accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.
Nurses may claim credit for activities approved for AMA PRA Category 1 Credit(s)™ in most states for up to 50% of the nursing requirement for recertification.
Medical Practice Executives
The American College of Medical Practice Executives accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME.
ScientiaCME is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 14.75 hours (1.475 CEUs) of continuing education. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit. ACPE # 0574-9999-20-001-L01-P. This activity is a Knowledge (K)-type activity.
While participants have one calendar month after the activity to provide learner information and take the post activity assessment and evaluation on ScientiaCME’s website, the course is only valid for credit on the day of the activity. Successful completion of the post-test and activity evaluation is required to obtain a certificate of completion.
This event is made possible by an educational grant from: